About Transcell Oncologics Private Limited
Data last updated:
Transcell Oncologics Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Tran-Scell Biologics Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the research and development sector. It was incorporated on 02 August 2017.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2017PTC118680. Its GSTIN is 36AAGCT3704K1Z8 (Telangana).
The company had an authorised share capital of ₹1.5 Lakh and a paid-up capital of ₹1.29 Lakh. It was led by directors including Uday Chatterjee and Vinayender Tulla.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at 8th Floor Western Pearl Kondapur, Hyderabad, Telangana, India – 500084.
As per the financials filed for FY 2023, the company reported a revenue of ₹4.04 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net loss of ₹3.24 Cr (net margin -80.3%) and EBITDA of -₹2.51 Cr (EBITDA margin -62.1%). Revenue has grown at a compounded annual rate (CAGR) of 67% over three years and 33% over five years.
The company was associated with 1 brand: Transcell Biolife. As per MCA filings, the company had satisfied charges of ₹27 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company. The company has 8 deals on record (6 funding rounds, 2 secondary share transfers), with disclosed funding of ₹11.58 Cr; the latest was in September 2021.
The last known website on record is transcellonco.science.
Company details
Contact details
Transcell Oncologics Private Limited's registered office is in Hyderabad, Telangana. Its website is transcellonco.science. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address8th Floor Western Pearl Kondapur, Hyderabad, Telangana, India – 500084
- IndustryResearch & Development, Research & Development
To see the full contact details of Transcell Oncologics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Transcell Oncologics operates one associated brand: Transcell Biolife. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Developer of stem cell technologies to screen small molecules for solid tumors | transcellonco.science |
Business activity
The main business activity of Transcell Oncologics is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Transcell Oncologics Private Limited, buy the company report.
Financials of Transcell Oncologics Private Limited
FY 2023 filings availableTranscell Oncologics Private Limited reported revenue of ₹4.04 Cr (up 3% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 33% over five years, including 3% growth in the latest year. EBITDA fell 116% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.51 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.24 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -62.1% | ||||
| Net Profit Margin | -80.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Transcell Oncologics Private Limited, buy the company report.
Board of directors of Transcell Oncologics Private Limited
Transcell Oncologics has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Uday Chatterjee | Director | 05 Jul 2021 | 5 Years 3 Months | As last reported |
| Vinayender Tulla Also directs: Tran-Scell Biologics Private Limited, Joy Retail & Technologies Private Limited, Vandanam Constructions Private Limited and 5 more | Director | 02 Aug 2017 | 9 Years 3 Months | As last reported |
| Subhadra Dravida | Director | 02 Aug 2017 | 9 Years 3 Months | As last reported |
Auditor
Transcell Oncologics Private Limited is audited by KAVADAPU AND ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KAVADAPU AND ASSOCIATES | FY 2021 | 017380S |
Shareholding
The shareholding of Transcell Oncologics Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Transcell Oncologics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Jul 2021 | 100470061 | Hdfc Bank Limited | ₹27 Lakh | Satisfied |
To see the full charge records of Transcell Oncologics Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Transcell Oncologics Private Limited has 8 deals on record (6 funding rounds, 2 secondary share transfers), with disclosed funding of ₹11.58 Cr; the latest was in September 2021.
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2021 | Funding round | ₹5.7 Cr | Investors: 4 individuals |
| Nov 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Jyoti Sagar Family Office |
| Jul 2020 | Funding round | ₹89.2 Lakh | Investors: 4 individuals |
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: Tran-Scell Biologics Private Limited Seller: an individual |
| Sep 2019 | Funding round | ₹1.44 Cr | Investors: Medmaxx Healthcare Private Limited , 3 individuals |
To see the full deal history of Transcell Oncologics Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Transcell Oncologics Private Limited has 1 court case on record: 1 filed by Transcell Oncologics. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Hyderabad | Court case (C.P.(CAA)) | Filed by the company | Disposed |
To see the full case history of Transcell Oncologics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Transcell Oncologics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Transcell Oncologics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCT3704K1Z8 | Telangana | Active | 01 Aug 2021 |
To see the full GST registrations and return filing status of Transcell Oncologics Private Limited, buy the company report.
Recent activity
Transcell Oncologics Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Uday Chatterjee ceased to be Additional Director on 30 Nov 2021.
Frequently asked questions
Transcell Oncologics has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Transcell Oncologics was a private limited company based in Hyderabad, Telangana, India. The company worked in the research and development industry. It was incorporated on 02 August 2017 and is registered under CIN U74999TG2017PTC118680. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Transcell Oncologics was incorporated on 02 August 2017. It is registered with the Registrar of Companies, Hyderabad.
Transcell Oncologics had 3 directors:
- Uday Chatterjee - Director
- Vinayender Tulla - Director
- Subhadra Dravida - Director
The CIN (Corporate Identification Number) of Transcell Oncologics is U74999TG2017PTC118680. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Transcell Oncologics is at 8th Floor Western Pearl Kondapur, Hyderabad, Telangana, India – 500084.
Transcell Oncologics can be reached through the website transcellonco.science. Its registered office is in Hyderabad, Telangana, India.
The latest financial statements of Transcell Oncologics on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Transcell Oncologics is 36AAGCT3704K1Z8, registered in Telangana.
Transcell Oncologics operated in the research and development industry.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
